Effect of ketorolac infiltration on analgesia after cesarean section

effect of ketorolac wound infiltration on caesarian post operative pain

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220706055402N6

Enrollment

Registered

2024-10-05

Start date

2024-10-12

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Investigating the effect of using wound infiltration of ketorolac after cesarean section to reduce post operative pain. Pain, unspecified

Interventions

Intervention 1: Intervention group(K): after blinding receive 0.5mg/kg ketorolac via caesarian wound infiltration then proceed to receive routine pain control with diclofenac suppository PRN. Interven

Eligibility

Sex/Gender

Female

Age

18 Years to 38 Years

Inclusion criteria

Inclusion criteria: Pregnant women aged 18-38 are candidates for elective caesarean section and have undergone spinal anesthesia for the operation.

Exclusion criteria

Exclusion criteria: Absence or withdrawal of consent coagulation disorders history of narcotics and sedatives abuse history of allergy and drug reaction to the studied drugs severe mental disorders conversion of spinal anesthesia to general anesthesia

Design outcomes

Primary

Measure	Time frame
Visual Analogue Scale (VAS). Timepoint: 0 hour(at the time of intervention), 1h, 6h, 12h, 24h later. Method of measurement: (0 = no pain and 10 = worst imaginable pain) is measured.	—

Secondary

Measure	Time frame
Mean arterial blood pressure (MAP). Timepoint: It will be measured at time zero, 1 hour later, 6, 12 and 24 hours later. Method of measurement: Reading from the monitoring device / manually.;Heart rate. Timepoint: It will be measured at time zero, 1 hour later, 6, 12 and 24 hours later. Method of measurement: Reading from the monitoring device / manually.;Oxygen Saturation (SpO2). Timepoint: It will be measured at time zero, 1 hour later, 6, 12 and 24 hours later. Method of measurement: Reading from the monitoring device / portable pulseoxymetry.;Total analgesic dose. Timepoint: through the day after surgery. Method of measurement: administered analgesic dose sum.;Rescue analgesic time. Timepoint: through the day after surgery. Method of measurement: time distance between end of surgery and first request of pain relief.;Overall satisfaction score. Timepoint: 24h later. Method of measurement: Likert scale (1-5).	—

Measure

Time frame

Mean arterial blood pressure (MAP). Timepoint: It will be measured at time zero, 1 hour later, 6, 12 and 24 hours later. Method of measurement: Reading from the monitoring device / manually.;Heart rate. Timepoint: It will be measured at time zero, 1 hour later, 6, 12 and 24 hours later. Method of measurement: Reading from the monitoring device / manually.;Oxygen Saturation (SpO2). Timepoint: It will be measured at time zero, 1 hour later, 6, 12 and 24 hours later. Method of measurement: Reading from the monitoring device / portable pulseoxymetry.;Total analgesic dose. Timepoint: through the day after surgery. Method of measurement: administered analgesic dose sum.;Rescue analgesic time. Timepoint: through the day after surgery. Method of measurement: time distance between end of surgery and first request of pain relief.;Overall satisfaction score. Timepoint: 24h later. Method of measurement: Likert scale (1-5).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Moftakhar

Ahvaz University of Medical Sciences

moftakhar-f@ajums.ac.ir+98 61 3338 3372

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026